LEDDARTECH LAUNCHES THE LEDDAR PIXELL, AN EXCEPTIONALLY DEPENDABLE AND DURABLE COCOON LIDAR FOR AUTONOMOUS VEHICLES

This 3D solid-state LiDAR cocoon solution is specially designed for autonomous vehicles such as shuttles, robotaxis, commercial and delivery vehicles ‒ enabling best-in-class safety through enhanced detection and robustness
 
QUEBEC CITY, Sept 10 (Bernama-GLOBE NEWSWIRE) -- LeddarTech®, an industry leader in LiDAR technology who provides the most versatile and scalable auto and mobility LiDAR platform™ in the market, introduces the Leddar™ Pixell a 3D flash LiDAR powered by the LCA2 LeddarEngine , designed explicitly for autonomous vehicles.

Leddar™ Pixell provides highly dependable detection of pedestrians, cyclists and other obstacles in the vehicle’s surroundings and is suitable for perception platforms that are developed to ensure the safety and protection of passengers and Vulnerable Road Users (VRU). The Leddar Pixell is an optimal detection cocoon solution for autonomous vehicle deployment and has already been adopted by over a dozen leading autonomous vehicle providers in North America and Europe.

Key Leddar™ Pixell Benefits:

• Dependable object and VRU detection:
  • Full-coverage over 180° field of view
  • No dead zones or blind spots
• Exceptional durability
  • 3D Flash, solid-state design with no moving parts
  • IP67 enclosure with impact-resistant windows and automotive-grade connectors

 
Watch the Leddar™ Pixell video

The Leddar Pixell has been shortlisted for the “Best in Class Perception System” award by Autosens. The winners will be announced on September 18 in Brussels.

“Leddar Pixell compensates for the limitations of mechanical scanning LiDAR used for geo-positioning which generate blind areas that can reach several meters” stated Michael Poulin, Vice-President of Product Management at LeddarTech. “By enabling superior dependability of detection in the vehicle’s surroundings without any dead zones or blind spots, Leddar™ Pixell uniquely answers the urgent market requirements to deploy autonomous vehicles with the highest degree of safety for passengers and road users. In addition to autonomous vehicles, the sensor is a highly efficient detection solution to cover critical blind spots on large commercial vehicles such as trucks and buses, contributing to increased road safety.”, continued Mr. Poulin.

Leddar™ Pixell integrates LeddarTech’s patented technology embedded in the state-of-the-art LCA2 LeddarEngine^TM, which consists of a highly integrated LeddarCore™ SoC and LeddarSP digital signal processing software. LeddarTech also offers the LeddarEngine to automotive LiDAR developers and other LiDAR makers, accelerating the availability of high quality, tailored LiDAR solutions to a broad and ever-growing range of LiDAR applications and markets.

LeddarTech will be officially unveiling Leddar™ Pixell in Canada at CAV19 Canada in Ottawa on Sept. 10^th, in  Europe at Autosens Brussels from September 17-19 and in the  US at Automotive LiDAR 2019 on September 25^th-26^th in Detroit, Michigan.

About LeddarTech®
LeddarTech is an industry leader providing the most versatile and scalable auto and mobility LiDAR platform based on the unique LeddarEngine^TM which consists of a suite of automotive-grade, functional safety certified SoCs working in tandem with proprietary LeddarSP^TM signal processing software. The company is responsible for several innovations in cutting-edge mobility remote-sensing applications, with over 70 patented technologies (granted or pending) enhancing ADAS and autonomous driving capabilities.

LeddarTech also serves the mobility market with solid-state high-performance LiDAR module solutions for autonomous shuttles, trucks, buses, delivery vehicles, and robotaxis. These modules are developed to support the mobility market but also to demonstrate the capabilities of LeddarTech’s auto and mobility platform as a basis for other LiDAR suppliers to build upon.

Additional information about LeddarTech is accessible at www.LeddarTech.com, and on LinkedIn, Twitter, Facebook, and YouTube.

Contact: Daniel Aitken, Vice President of Marketing and Communications, LeddarTech
Tel.: +1-418-653-9000 ext. 232 Daniel.Aitken@Leddartech.com

Leddar, LeddarTech, LeddarEngine, LeddarSP, LeddarCore, and LeddarTech logos are trademarks or registered trademarks of LeddarTech Inc. All other brands, product names, and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

Two photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/37f4e325-a512-480a-80a5-62c4aa4b5788

https://www.globenewswire.com/NewsRoom/AttachmentNg/8da03700-05e1-4834-9964-f76d26aa3786

Source: LeddarTech inc.
 
--BERNAMA

EUROMONITOR INTERNATIONAL LAUNCHES NEW WHITEPAPER 'HOW TO BECOME A SUSTAINABLE BRAND'

LONDON, Sept 10 (Bernama-BUSINESS WIRE) -- Global market research company Euromonitor International launched today a new whitepaper, ‘How to become a sustainable brand’.

This whitepaper explores how companies can utilise different strategies to align with new government policies and consumer behaviours, while maximising profitability. More consumers are proactively leading a sustainable lifestyle. According to Euromonitor International’s latest sustainability survey, 54 percent of global consumers believe ethical purchase decisions will make a difference.

With sustainability becoming key for business success, investors are moving away from short-term profit and injecting capital into more sustainable companies. The market for sustainable packaged food and non-alcoholic drinks was worth over US$ 1 trillion in 2018 and is expected to increase by 18.5 percent by 2023, according to Euromonitor International’s latest research.

Opposing the throwaway culture, one-fifth of the global consumer population prefer to repair damaged items. This shift in consumer behaviour is leading brands to respond accordingly. For example, outdoor clothing brand Patagonia, offers a free repair service to increase product longevity and reduce waste generation.

“While sustainability has long been somewhere on the agenda for many, we are now moving from a ‘knowledge to action’ culture, to a ‘purpose to advocacy’ one.” concludes Senior Consultant, Maria Coronado Robles.

To download the complete whitepaper for free, please click here 

About Euromonitor International

Euromonitor International is the world’s leading provider for global business intelligence and strategic market analysis. We have more than 40 years of experience publishing international market reports, business reference books and online databases on consumer markets.

View source version on businesswire.com: 
https://www.businesswire.com/news/home/20190909005012/en/

Contact

Carol Li
Communications Executive - Euromonitor International
Tel: +44 2078515024 Ext 5222
Carol.li@euromonitor.com

Source : Euromonitor International

APTORUM GROUP ANNOUNCES THE DEVELOPMENT OF MICROBIOME DRUG CANDIDATE TARGETING OBESITY AND REPURPOSED DRUG CANDIDATES TARGETING NEUROBLASTOMA

NEW YORK, Sept 10 (Bernama-BUSINESS WIRE) -- Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces the development of two preclinical drug candidates which target obesity and neuroblastoma, respectively.

About CLS-1: Treatment of obesity via modulation of chemical signaling relating to gut microbiota

Under the recently-announced microbiota modulation platform operated by Aptorum Group’s wholly-owned subsidiary Claves Life Sciences Limited, we have commenced the preclinical development of macromolecule candidate CLS-1 targeting the treatment of obesity. CLS-1 is undergoing lead optimization and is expected to progress into the IND enabling stage in 2020.

The prevalence of obesity continues to escalate globally; however, there is no current optimal therapy for this condition¹. For the majority of obese patients, conventional medical therapies (i.e., diet, exercise, behavioral counseling) often have a high failure rate for the long term². We believe current pharmacotherapy has limited efficacy and is associated with substantial safety issues, and this will provide immeasurable market opportunity for CLS-1.

Chemical signaling of gut microbiota is known to be one of the major causes of obesity¹. CLS-1 is an orally administered non-absorbable macromolecule that modulates the metabolite excreted by gut microbiota with high affinity and specificity. In this way, we believe the absorption of this particular metabolite, which is linked to obesity, can be inhibited.

Aptorum Group is also pursuing two further indications based on the modulation of microbiota based chemical signaling involving the above large molecule technology, which we believe to be highly scalable and we hope to be making further announcements regarding our efforts in due course.

About SACT-1: Repurposed Drug Candidates for the Treatment of Neuroblastoma

Under the recently announced Smart-ACT^TM computational drug discovery platform operated by our wholly-owned subsidiary Smart Pharma Group, Aptorum Group has completed computational screening of approximately 1,615 marketed drugs against 3 therapeutic target proteins to potentially tackle poor prognosis of neuroblastoma, i.e., a rare type of children’s cancer that forms in certain types of nerve tissue and most frequently in the adrenal glands as well as spine, chest, abdomen or neck, especially in children³. For the high-risk group, the 5-year survival rate of this condition is around 40-50% as observed by the American Cancer Society.⁴ Aptorum Group has identified an array of repurposed candidates and has proceeded to evaluate them in cell-based and animal models in order to validate the candidates’ usage for such new indication and potential efficacies.

Aptorum Group is also pursuing two further indications under the Smart-ACT^TM drug discovery platform and hopes to be making further announcements regarding our research in due course.

About Aptorum Group Limited

Aptorum Group Limited (Nasdaq: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum Group is pursuing therapeutic projects in neurology, infectious diseases, gastroenterology, oncology and other disease areas.

For more information about Aptorum Group, please visit www.aptorumgroup.com.

About Claves Life Sciences Limited

Claves Life Sciences Limited is a wholly-owned therapeutics subsidiary of Aptorum Group Limited. Claves focuses on the clinical development of therapeutic candidates related to the field of gastroenterology. The potential candidates under review and potentially developed focus on the modulation of gut microbiota-derived metabolites, for the prevention or treatment of diseases. Claves is also exploring a gut microbiota modulation platform that can generate novel customized candidates capable of fine-tuning levels of gut metabolites, potentially treating a wide range of medical conditions.

About Smart Pharma Group

Smart Pharma Group includes Smart Pharmaceutical Limited Partnership, SMTPH Limited and its subsidiaries. The Smart Pharma Group is wholly owned by Aptorum Group Limited. Smart Pharma Group focuses on systematically repurposing existing approved drugs for the treatment of a large array of orphan diseases. Smart Pharma Group conducts both computational based screening and preclinical validations in advancing the development of its repurposed candidates.

For more information about Smart Pharma Group, please visit www.smtph.com.

Disclaimer and Forward-Looking Statements

This press release includes statements concerning Aptorum Group Limited and its future expectations, plans and prospects that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “may,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue,” or the negative of these terms or other similar expressions. Aptorum Group has based these forward-looking statements, which include statements regarding projected timelines for application submissions and trials, largely on its current expectations and projections about future events and trends that it believes may affect its business, financial condition and results of operations. These forward-looking statements speak only as of the date of this press release and are subject to a number of risks, uncertainties and assumptions including, without limitation, risks related to its announced management and organizational changes, the continued service and availability of key personnel, its ability to expand its product assortments by offering additional products for additional consumer segments, development results, the company’s anticipated growth strategies, anticipated trends and challenges in its business, and its expectations regarding, and the stability of, its supply chain, and the risks more fully described in Aptorum Group’s Form 20-F and other filings that Aptorum Group may make with the SEC in the future. As a result, the projections included in such forward-looking statements are subject to change. Aptorum Group assumes no obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
 

1 Protein Cell. May; 9(5): 397–403. 2 Obes Surg. 2012 Jun;22(6):956-66 3 https://www.cancer.gov/publications/dictionaries/cancer-terms?expand=N 4 See https://www.cancer.org/cancer/neuroblastoma/detection-diagnosis-staging/survival-rates.html.

View source version on businesswire.com:
https://www.businesswire.com/news/home/52086594/en

Contact

Investors:
Tel: +852 2117 6611
Email: investor.relations@aptorumgroup.com

Media:
Tel: + 852 2117 6611
Email: info@aptorumgroup.com

Source : Aptorum Group Limited

SiliconIndia recognises Singsys as 'Company of The Year, 2019'

KUALA LUMPUR, Sept 10 -- Singsys, a globally celebrated multinational corporation headquartered at Singapore has been ranked 1st in India’s ‘Prominent Companies List' in Laravel Development for 2019 by SiliconIndia.

Essentially, it is a quantum leap for the firm, emerging as India's top company from having already upheld similar top recognitions in Singapore.

This accomplishment cements Singsys’ commitment towards curating and nurturing the culture for building and sustaining its philosophy of high-trust and high-quality.

Singsys has also been recognised as the Laureates for consistently getting featured for its exemplary services for the Indian software industry, with its earlier significant ‘Startup of the Year’ recognition in 2014.

This recent achievement showcases Singsys' commitment to upscale state-of-the-art technologies towards rendering all-inclusive services.

As an organisation, Singsys has always been at the leading edge in nurturing talented individuals with knowledge, skill sets and competencies, and aligned its human resource function with the fast-changing business environment.

-- BERNAMA

"JAPAN MEDIA ARTS DISTRIBUTED MUSEUM" OPENS AT ABOUT 10 LOCATIONS

SAPPORO, Japan and TOKYO, Sept. 6, 2019 /Kyodo JBN-AsiaNet/ --
 
-New Art Exhibition Inspired by Regional Cultural Artifacts Showcases Charms of Japanese Culture-
 
Japan Media Arts Distributed Museum Office is proud to announce the opening of an exhibition, "Japan Media Arts Distributed Museum," in approximately 10 locations, including airports in Japan, as part of a new initiative funded by International Tourist Taxes by the Agency for Cultural Affairs, Government of Japan. As the first endeavor of this initiative, the office is starting off with a large-scale video installation and a decorative window art piece starting Friday, August 30, the first year of Reiwa (2019) at the New Chitose Airport International Arrivals Concourse.
 
The exhibition marks the start of a new initiative for visitors to Japan called "Japanese cultural media arts dissemination initiative at airports and other institutions" by the Agency for Cultural Affairs, Government of Japan.
  
The artists and creators featured in this exhibition capture the cultural resources borne out of various local cultures through fresh perspectives. By showcasing the works of media art in places like airports, which serve as gateways to these regions, the office invites visitors to explore the true spirit of these cultures throughout their travel.
  
At the New Chitose Airport, animated artwork by creative company "NAKED" highlighting the ethnic Ainu minority's indigenous culture is showcased in the International Arrivals Concourse. The Ainu people use the name "kamuy" to refer to animals, nature, and the many phenomena that are beyond human understanding. The animation captures the spectacular nature of Hokkaido where the various "kamuy" abide. The story welcomes visitors from other regions and expresses the spirit of the Ainu people. Additionally, a decorative artwork inspired by traditional Ainu patterns is exhibited on the concourse window, transforming the International Arrivals Concourse into a gateway to Japanese culture by promoting "media art meets Ainu culture".
  
*This exhibition is displayed within the International Arrivals Concourse, and is not available for viewing by the general public. Only passengers arriving on international flights are able to see this exhibition. Other information, including future exhibitions at other airports, will be announced when details are confirmed.
 
Overview of Exhibition at New Chitose Airport
Date: Opening Friday, August 30, 2019, the first year of Reiwa (2019)
Location: New Chitose Airport (Chitose City, Hokkaido) International Arrivals Concourse
Content: Artwork inspired by Ainu culture including a large-scale (15 meters in height) video installation curated by NAKED and a decorative window art piece  incorporating traditional Ainu patterns
 
Official website: https://jmadm.jp/en/
 
For details, please visit:
https://kyodonewsprwire.jp/attach/201909040418-O1-nsrWUm3y.pdf
 
Source: Japan Media Arts Distributed Museum Office
 
--BERNAMA

PRA Health Sciences Inc announces US$500 million share repurchase programme

KUALA LUMPUR, Sept 4 -- PRA Health Sciences Inc (the Company) today announced its Board of Directors (the Board) has authorised a US$500 million share repurchase programme, effective immediately. (US$1 = RM4.21)

Under the programme, the Company is authorised to repurchase shares of its common stock through open market purchases, privately-negotiated transactions, secondary offerings, block trades or otherwise in accordance with all applicable securities laws and regulations, including through trading plans complying with the rules and regulations of the Securities and Exchange Commission.

The repurchase programme expires on Dec 31, 2021, according to a statement.

The closing of such share repurchase is conditioned on, and expected to occur simultaneously with, the closing of the secondary offering, subject to the satisfaction of other customary conditions.

The Company intends to fund such share repurchase with the proceeds of a US$300 million incremental term loan under its existing credit facilities.

Following the completion of such share repurchase, the Company will have approximately US$200 million of remaining availability under the share repurchase programme.

-- BERNAMA

Music to the ears: Audio Network-Musiio partnership harnesses AI power

KUALA LUMPUR, Sept 5 (Bernama) -- Audio Network Limited has partnered Musiio to explore the power of Artificial Intelligence (AI) to improve customer service and delivery.

This industry will first equip the global music company with added interface to their existing search platform, to make their catalogue of over 170,000 tracks even more discoverable, whilst keeping the human touch that Audio Network has always been known for.

“Many AI tools for music are clever technology hacks in search of an actual problem to solve, but our partnership with Musiio for extending music search and recommendations is about solving real problems for our customers,” said Audio Network chief product officer, Matthew Hawn.

“Blending Musiio's technology with our expert human curation will mean our artistes and composers' music is more accessible to more customers globally.”

Musiio provides a new way of listening to music at scale, easily searching up to one million tracks in under two seconds and supercharging a team of music researchers to increase their efficiency in responding to music briefs.

Audio Network Limited is one of the world’s largest independent creators and publishers of original high-quality music for use in film, television, advertising and digital media.

More information at https://www.audionetwork.com.

-- BERNAMA